XtalPi is a biotech company that provides fully integrated drug discovery solutions and chemical services. Specializing in small-molecule and biologics discovery, it uses its proprietary AI platforms like ID4 and XupremAb to accelerate drug development. The company combines automation, computational chemistry, and solid-state chemistry to support every stage of medicinal research. With high-throughput synthesis and automated crystallization platforms, it streamlines and optimizes drug discovery, helping pharmaceutical companies.
📋 Overview of XtalPi
📙 About XtalPi
💰 Recent Investors of XtalPi
Morningside Venture Capital, Orbimed, Investor
© 2025 Bot Memo. All Rights Reserved.
